Drug Profile
Research programme: anti-hCG monoclonal antibodies - Abgenix/AVI BioPharma
Alternative Names: Xactin antibodiesLatest Information Update: 12 Jan 2007
Price :
$50
*
At a glance
- Originator Abgenix; AVI BioPharma
- Class Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 21 Feb 2005 No development reported - Preclinical for Cancer in USA (unspecified route)
- 15 Jan 1999 New profile
- 15 Jan 1999 Preclinical development for Cancer in USA (Unknown route)